Skip to main content
S

SD BIOTECHNOLOGIES CO., LTD. — Investor Relations & Filings

Ticker · 217480 ISIN · KR7217480003 KO Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2025-06-30 Delisting Announcement
Country KR South Korea
Listing KO 217480

About SD BIOTECHNOLOGIES CO., LTD.

https://snpbeauty.com/

SD BIOTECHNOLOGIES CO., LTD. is a company that engages in the research, development, manufacturing, and sale of cosmetics and skincare products. Operating as a 'Total Skin Solution' provider, it focuses on developing safe and innovative cosmeceutical products based on skin science and rigorous testing. The company's primary brand, SNP, offers a range of solutions grounded in scientific evidence and skincare expertise. Its product portfolio includes basic skincare, mask packs, trouble care products, and healthcare foods, all formulated through extensive research and development to ensure efficacy.

Recent filings

Filing Released Lang Actions
기타시장안내 (기업심사위원회 심의결과 안내)
Delisting Announcement Classification · 1% confidence The document is a short announcement from the Korea Exchange regarding the delisting review results for SD Biotechnologies. It explicitly states that the Corporate Review Committee has decided on 'delisting' and outlines the timeline for the next steps (KOSDAQ Market Committee meeting). This is a formal notice regarding the status of the company's listing on the exchange, which fits the definition of a Delisting Announcement.
2025-06-30 Korean
기타시장안내 (개선계획 이행내역서 제출)
Legal Proceedings Report Classification · 1% confidence The document is a short regulatory notice from the Korea Exchange regarding SD Biotechnologies. It informs the market about the submission of an 'Improvement Plan Implementation Report' following a period of trading suspension and outlines the upcoming regulatory timeline for the Corporate Review Committee to decide on potential delisting. Since this is a regulatory announcement regarding compliance and listing status rather than a financial report or a specific corporate action like a dividend or director dealing, it falls under the general regulatory filing category.
2025-05-29 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the 18th fiscal period (2025-01-01 to 2025-03-31) submitted to the Financial Supervisory Service and Korea Exchange. It contains detailed financial information, business descriptions, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean
기타시장안내 ((주)에스디생명공학 개선기간 종료에 따른 상장폐지 여부 결정 안내 )
Delisting Announcement Classification · 1% confidence The document is a short regulatory notice from the Korea Exchange regarding the status of SD Biotechnologies following the end of an improvement period. It outlines the timeline for the company to submit documentation and the subsequent process for the exchange to decide on potential delisting. As this is a regulatory announcement regarding listing status and not a formal delisting notice itself, it falls under the general regulatory filing category.
2025-05-08 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official report of the results of a General Meeting of Shareholders (AGM). It details the outcomes of voting on agenda items such as financial statement approval, director appointments, and remuneration limits. This falls under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-03-27 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a regulatory filing from the Korea Exchange (KRX) system titled '감사보고서 제출' (Submission of Audit Report). It provides a summary of financial data, audit opinions, and key financial metrics (assets, liabilities, profit/loss) for the current and previous fiscal years. While it contains financial data, it is a standardized regulatory announcement form used to notify the market that the audit report has been submitted, rather than the full, multi-page audit report document itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2024
2025-03-19 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.